1.55
Equillium Inc stock is traded at $1.55, with a volume of 2.03M.
It is up +5.44% in the last 24 hours and up +71.76% over the past month.
Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its product candidates either independently or through partnerships, or otherwise monetize its pipeline through strategic transactions. Itolizumab (EQ001), a clinical-stage product candidate, is an anti-CD6 immune-modifying monoclonal antibody, or mAb, that selectively targets the CD6-ALCAM signaling pathway to downregulate pathogenic T effector cells while preserving T regulatory cells critical for maintaining a balanced immune response. The company's other clinical-stage and pre-clinical-stage candidates include EQ101 and EQ302.
See More
Previous Close:
$1.47
Open:
$1.47
24h Volume:
2.03M
Relative Volume:
3.06
Market Cap:
$94.38M
Revenue:
$45.91M
Net Income/Loss:
$-4.62M
P/E Ratio:
-11.06
EPS:
-0.1402
Net Cash Flow:
$-21.51M
1W Performance:
+14.81%
1M Performance:
+71.76%
6M Performance:
+400.00%
1Y Performance:
+109.46%
Equillium Inc Stock (EQ) Company Profile
Name
Equillium Inc
Sector
Industry
Phone
(858) 412-5302
Address
2223 AVENIDA DE LA PLAYA, LA JOLLA, CA
Compare EQ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
EQ
Equillium Inc
|
1.55 | 89.51M | 45.91M | -4.62M | -21.51M | -0.1402 |
|
VRTX
Vertex Pharmaceuticals Inc
|
453.74 | 116.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
773.94 | 82.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.25 | 52.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.90 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.09 | 37.61B | 447.02M | -1.18B | -906.14M | -6.1812 |
Equillium Inc Stock (EQ) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-28-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Oct-29-21 | Resumed | Stifel | Buy |
| Sep-15-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-14-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-10-20 | Resumed | Stifel | Buy |
| Feb-22-19 | Initiated | SVB Leerink | Outperform |
View All
Equillium Inc Stock (EQ) Latest News
Equillium (NASDAQ:EQ) COO Christine Zedelmayer Sells 100,000 Shares - MarketBeat
Is Equillium Inc. stock a top pick in earnings seasonIPO Watch & Stepwise Entry/Exit Trade Alerts - Улправда
Can Equillium Inc. stock sustain free cash flow growthPortfolio Return Report & Fast Moving Market Watchlists - Улправда
Will Equillium Inc. stock reach all time highs in 2025Quarterly Trade Summary & Consistent Profit Trade Alerts - Улправда
Is Equillium Inc. (0FY) stock trading at attractive multiplesQuarterly Risk Review & Consistent Profit Focused Trading Strategies - Bölüm Sonu Canavarı
Will Equillium Inc. stock benefit from sector rotation2025 Valuation Update & Weekly High Conviction Ideas - DonanımHaber
Will Equillium Inc. (0FY) stock maintain strong growthWeekly Trading Summary & Fast Momentum Entry Tips - DonanımHaber
Aug Wrap: Can Equillium Inc. stock sustain free cash flow growthEarnings Trend Report & Low Risk High Win Rate Picks - Улправда
Christine Zedelmayer Sells 11,900 Shares of Equillium (NASDAQ:EQ) Stock - MarketBeat
Christine Zedelmayer Sells 23,804 Shares of Equillium (NASDAQ:EQ) Stock - MarketBeat
Insider Sell: Christine Zedelmayer Sells 35,704 Shares of Equill - GuruFocus
COO Zedelmayer Sells 35,704 ($47.5K) Of Equillium Inc [EQ] - TradingView — Track All Markets
Equillium Senior VP and COO Christine Zedelmayer Sells Shares - TradingView — Track All Markets
JANUS HENDERSON GROUP PLC Acquires Significant Stake in Equilliu - GuruFocus
What is Equillium Inc (EQ) Stock Return on Shareholders’ Capital? - setenews.com
EQ FinancialsIncome Statement - Quiver Quantitative
EQ Insider Trading - Quiver Quantitative
Equillium (NASDAQ:EQ) Stock Price Up 2.6% – Should You Buy? - Defense World
Equillium (NASDAQ:EQ) Stock Price Up 2.6%Should You Buy? - MarketBeat
Can Equillium Inc 0FY stock attract analyst upgrades2025 Earnings Impact & Weekly Return Optimization Alerts - moha.gov.vn
Will Equillium Inc. stock deliver shareholder value2025 Market Sentiment & Weekly High Return Opportunities - Newser
Why Equillium Inc. (0FY) stock could rally stronglyEarnings Overview Summary & Low Risk High Reward Ideas - Newser
Can Equillium Inc. (0FY) stock survive global slowdownTrend Reversal & Consistent Growth Stock Picks - Newser
Can Equillium Inc. stock maintain growth trajectory2025 Big Picture & Growth Oriented Trade Recommendations - Newser
Equillium Inc (EQ) can make a big difference with a little luck - setenews.com
Will Equillium Inc. (0FY) stock outperform small cap peersJuly 2025 Short Interest & Weekly High Conviction Trade Ideas - Newser
How Equillium Inc. (0FY) stock expands through international marketsJuly 2025 Retail & Daily Chart Pattern Signals - Newser
What technical patterns form on Equillium Inc. (0FY) stock chartsEarnings Growth Report & Long-Term Growth Portfolio Plans - Newser
What hedge fund activity signals for Equillium Inc. stockJuly 2025 Sector Moves & Short-Term High Return Ideas - Newser
EQ SEC FilingsEquillium 10-K, 10-Q, 8-K Forms - Stock Titan
Will Equillium Inc. (0FY) stock outperform global peersGold Moves & Verified Momentum Stock Alerts - Newser
Is Equillium Inc. (0FY) stock at risk of policy regulationJobs Report & Technical Pattern Based Buy Signals - Newser
Can Equillium Inc. (0FY) stock attract analyst upgradesEarnings Recap Report & Verified Chart Pattern Signals - Newser
Market Fear: Can Equillium Inc. stock sustain free cash flow growthJuly 2025 Drop Watch & Technical Buy Zone Confirmation - BỘ NỘI VỤ
Equillium Inc. (EQ) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Equillium, Inc. (0A4D.L) Stock Price, News, Quote & History - Yahoo! Finance Canada
Equillium SVP Zedelmayer sells $7.7k in stock By Investing.com - Investing.com Nigeria
Equillium SVP Zedelmayer sells $7.7k in stock - Investing.com
COO Zedelmayer Sells 8,098 ($7.7K) Of Equillium Inc [EQ] - TradingView
[Form 4] Equillium, Inc. Insider Trading Activity - Stock Titan
COO Zedelmayer Files To Sell 8,098 Of Equillium Inc [EQ] - TradingView
Healthy Upside Potential: Equillium Inc (EQ) - Setenews
Equillium Reports Q3 Loss Amid Strategic Focus - MSN
Why Equillium Inc. (0FY) stock remains top ratedDividend Hike & Real-Time Stock Entry Alerts - newser.com
How Equillium Inc. stock performs in weak economy2025 Market Outlook & Smart Swing Trading Alerts - newser.com
How Equillium Inc. stock performs in rising dollar environmentWatch List & Trade Opportunity Analysis - newser.com
How buybacks impact Equillium Inc. stock valueJuly 2025 Sector Moves & Verified Short-Term Plans - newser.com
Equillium to Participate in Upcoming Investor Conferences - The Manila Times
How Equillium Inc. stock performs during Fed tightening cyclesAnalyst Upgrade & Daily Oversold Stock Bounce Ideas - newser.com
Equillium, Inc. to Participate in Upcoming Investor Conferences in December 2025 - Quiver Quantitative
Equillium (Nasdaq: EQ) to Present at Piper Sandler and Evercore ISI Healthcare Conferences - Stock Titan
Equillium Inc Stock (EQ) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):